![Revision of omalizumab dosing table for dosing every 4 instead of 2 weeks for specific ranges of bodyweight and baseline IgE - ScienceDirect Revision of omalizumab dosing table for dosing every 4 instead of 2 weeks for specific ranges of bodyweight and baseline IgE - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0273230014002955-gr7.jpg)
Revision of omalizumab dosing table for dosing every 4 instead of 2 weeks for specific ranges of bodyweight and baseline IgE - ScienceDirect
Novartis data show more patients are completely symptom-free from chronic spontaneous urticaria with ligelizumab (QGE031) than Xolair® 300 mg | Novartis
Omalizumab dosing via the recommended card versus use of the published formula To the Editor: Before the Food and Drug Administr
Xolair 150 mg solution for injection in pre-filled syringe - Summary of Product Characteristics (SmPC) - (emc)
![Xolair 150 mg solution for injection in pre-filled syringe - Summary of Product Characteristics (SmPC) - (emc) Xolair 150 mg solution for injection in pre-filled syringe - Summary of Product Characteristics (SmPC) - (emc)](https://www.medicines.org.uk/emc/images/spc/spc~24912~20~192291B.png)